Century Therapeutics (IPSC) News Today $0.51 -0.02 (-4.14%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.50 0.00 (-0.45%) As of 08/8/2025 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IPSC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Century Therapeutics (IPSC) to Release Quarterly Earnings on ThursdayAugust 7 at 2:36 AM | americanbankingnews.comCentury Therapeutics (NASDAQ:IPSC) Shares Down 8.7% - Here's WhyJuly 30, 2025 | marketbeat.comCentury Therapeutics Inc. Stock Grades | IPSC | Barron'sJuly 16, 2025 | barrons.comUniversity City biotech Century Therapeutics is cutting 72 jobs, about half its workforceJuly 11, 2025 | msn.comCentury Therapeutics to Cut 51% of WorkforceJuly 8, 2025 | marketwatch.comCentury Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum - NasdaqJune 27, 2025 | nasdaq.comCentury Therapeutics, Inc. (IPSC) - Yahoo FinanceJune 26, 2025 | sg.finance.yahoo.comIPSC Century Therapeutics, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comCentury Therapeutics to Present Preclinical Data at EULAR 2025 CongressMay 31, 2025 | msn.comCentury Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 CongressMay 28, 2025 | globenewswire.comQ2 EPS Estimate for Century Therapeutics Lowered by AnalystMay 23, 2025 | marketbeat.comCentury Therapeutics, Inc.: Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 16, 2025 | finanznachrichten.deCentury Therapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 15, 2025 | globenewswire.comCentury Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual MeetingMay 1, 2025 | msn.comCentury Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual MeetingApril 28, 2025 | globenewswire.comPiper Sandler Remains a Buy on Century Therapeutics (IPSC)April 24, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Becton Dickinson (BDX), Intuitive Surgical (ISRG) and Century Therapeutics (IPSC)April 23, 2025 | markets.businessinsider.comCentury Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy AdvancesApril 17, 2025 | msn.comCentury Therapeutics price target lowered to $5 from $12 at GuggenheimMarch 21, 2025 | markets.businessinsider.comCentury Therapeutics Announces Pipeline Re-Prioritization to Focus on Transformational Programs and Extends Cash Runway into Q4 2026March 21, 2025 | nasdaq.comCentury Therapeutics (IPSC) Receives a Buy from Piper SandlerMarch 21, 2025 | markets.businessinsider.comCentury Therapeutics price target lowered to $2 from $4 at Piper SandlerMarch 21, 2025 | markets.businessinsider.comCentury Therapeutics Announces Strategic Pipeline Shift and 2024 Financial ResultsMarch 21, 2025 | msn.com3IPSC : Demystifying Century Therapeutics: Insights From 4 Analyst ReviewsMarch 21, 2025 | benzinga.comCentury Therapeutics Reports Full Year 2024 Financial Results and Provides Business UpdateMarch 19, 2025 | globenewswire.comCentury Therapeutics, Inc. (NASDAQ:IPSC) Given Average Recommendation of "Buy" by BrokeragesMarch 13, 2025 | marketbeat.comCentury Therapeutics (IPSC) Expected to Announce Quarterly Earnings on ThursdayMarch 6, 2025 | marketbeat.comLeerink Partnrs Has Strong Forecast for IPSC FY2024 EarningsFebruary 17, 2025 | marketbeat.comCentury Therapeutics, Inc. (NASDAQ:IPSC) Given Average Rating of "Buy" by AnalystsFebruary 16, 2025 | marketbeat.comFY2029 Earnings Estimate for IPSC Issued By Leerink PartnrsFebruary 15, 2025 | marketbeat.comLeerink Partners Remains a Buy on Century Therapeutics (IPSC)February 14, 2025 | markets.businessinsider.comCentury Therapeutics SVP sells shares worth $273 to cover taxesFebruary 5, 2025 | msn.comCentury Therapeutics COO Farid Adrienne sells $822 in stockFebruary 5, 2025 | msn.comCentury Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 14.0% in JanuaryFebruary 1, 2025 | marketbeat.comCentury Therapeutics, Inc. (NASDAQ:IPSC) Given Average Rating of "Buy" by BrokeragesJanuary 22, 2025 | marketbeat.comGuggenheim Reaffirms "Buy" Rating for Century Therapeutics (NASDAQ:IPSC)January 22, 2025 | marketbeat.comCentury Therapeutics (NASDAQ:IPSC) Receives "Buy" Rating from HC WainwrightJanuary 22, 2025 | marketbeat.comCentury Therapeutics launches cell therapy trial for autoimmune diseasesJanuary 21, 2025 | msn.comCentury Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 14.0% in DecemberJanuary 18, 2025 | marketbeat.comCentury Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Down 5.6% in DecemberJanuary 1, 2025 | marketbeat.comCentury Therapeutics price target lowered to $4 from $12 at Piper SandlerDecember 30, 2024 | markets.businessinsider.comCentury Therapeutics (NASDAQ:IPSC) Given New $4.00 Price Target at Piper SandlerDecember 30, 2024 | marketbeat.comPhiladelphia cell therapy developer loses Big Pharma partnership valued at over $3BDecember 17, 2024 | bizjournals.comFmr LLC Cuts Stake in Century Therapeutics, Inc. (NASDAQ:IPSC)December 14, 2024 | marketbeat.comCentury Therapeutics (NASDAQ:IPSC) Trading Down 4.3% - Here's What HappenedDecember 12, 2024 | marketbeat.comCentury Therapeutics to Present at Piper Sandler 36th Annual Healthcare ConferenceNovember 29, 2024 | msn.comLeerink Partners Reaffirms Their Buy Rating on Century Therapeutics (IPSC)November 28, 2024 | markets.businessinsider.comCentury Therapeutics to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 26, 2024 | globenewswire.comWhat is HC Wainwright's Forecast for IPSC FY2024 Earnings?November 8, 2024 | marketbeat.comWhat is William Blair's Forecast for IPSC FY2024 Earnings?November 8, 2024 | marketbeat.com Get Century Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IPSC and its competitors with MarketBeat's FREE daily newsletter. Email Address IPSC Media Mentions By Week IPSC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPSC News Sentiment▼0.000.38▲Average Medical News Sentiment IPSC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPSC Articles This Week▼11▲IPSC Articles Average Week Get Century Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IPSC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRBU News CYBN News OGI News DMAC News CRDF News RAPT News LYEL News ACRS News SLS News CLLS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IPSC) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Century Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Century Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
